Amicus Therap Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMICUS THERAP US, and when can generic versions of AMICUS THERAP US drugs launch?
AMICUS THERAP US has two approved drugs.
There are sixty-nine US patents protecting AMICUS THERAP US drugs.
There are three hundred and thirty-seven patent family members on AMICUS THERAP US drugs in forty-four countries and twenty-four supplementary protection certificates in seventeen countries.
Summary for Amicus Therap Us
International Patents: | 337 |
US Patents: | 69 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Drugs and US Patents for Amicus Therap Us
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 10,874,655 | ⤷ Subscribe | ⤷ Subscribe | ||||
Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 10,799,491 | ⤷ Subscribe | ⤷ Subscribe | ||||
Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 11,278,536 | ⤷ Subscribe | ⤷ Subscribe | ||||
Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 10,471,053 | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Amicus Therap Us Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2019217868 | ⤷ Subscribe |
Chile | 2018001773 | ⤷ Subscribe |
Chile | 2022002423 | ⤷ Subscribe |
Japan | 6026268 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Amicus Therap Us Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2787345 | 122016000090 | Germany | ⤷ Subscribe | PRODUCT NAME: MIGALASTAT ODER EIN SALZ DAVON, EINSCHLIESSLICH DES HYDROCHLORIDSALZES; REGISTRATION NO/DATE: EU/1/15/1082/001 20160526 |
2787345 | 1690052-4 | Sweden | ⤷ Subscribe | PRODUCT NAME: MIGALASTAT OR A SALT THEREOF, INCLUDING THE HYDROCHLORIDE SALT.; REG. NO/DATE: EU/1/15/1082 20160531 |
2787345 | 268 5025-2016 | Slovakia | ⤷ Subscribe | PRODUCT NAME: MIGALASTAT VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/15/1082 20160531 |
3201320 | CA 2024 00012 | Denmark | ⤷ Subscribe | PRODUCT NAME: CIPAGLUCOSIDASE ALFA; REG. NO/DATE: EU/1/22/1714 20230324 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.